US Stock MarketDetailed Quotes

SYRS Syros Pharmaceuticals

Watchlist
  • 0.2000
  • -0.0018-0.89%
Close Dec 20 16:00 ET
  • 0.2069
  • +0.0069+3.45%
Post 20:01 ET
5.37MMarket Cap-0.07P/E (TTM)

Syros Pharmaceuticals Key Stats

Syros Pharmaceuticals Q3 2024 Earnings Date

Currency:USDOct 31, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
360.00K
0
-360.00K
Miss Est.
-90.43%
-100.00%
-100.00%
EPS
-0.68
-0.16
+0.52
Beat Est.
+52.73%
+88.81%
+76.33%
Buy

Dec 22, 2024

Syros Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 450.000K--
Oct 31, 20242024/Q30.000 / 360.000K--
Jul 31, 20242024/Q20.000 / 460.000K--
May 14, 20242024/Q10.000 / 720.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 450.000K--
Oct 31, 20242024/Q30.000 / 360.000K--
Jul 31, 20242024/Q20.000 / 460.000K--
May 14, 20242024/Q10.000 / 720.000K--

Unlock Free Earnings Estimates

Syros Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 22, 2024

Buy

  • Buy

    40.00%
  • Hold

    60.00%
  • Sell

    0.00%

Price Target

No Data